Chong Kun Dang Pharmaceutical Corp. (KOSE: A185750)
Health Care · Pharmaceuticals · KR
₩66,900.00
-2.05% today · -17.5% 1Y
Chong Kun Dang Pharmaceutical Corp. (KOSE: A185750) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $636.04M.
Over the last twelve months the share price has lost 17.5%, trading between 63.00K and 98.10K.
Tweenvest scores Chong Kun Dang Pharmaceutical Corp. across four factors: quality 66/100, value 74/100, dividend 26/100. Its strongest factor is value.
A185750 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $636.04M
- Revenue (TTM)
- $1.14B
- P/E
- 11.29
- EPS
- 5,923.89
- Dividend yield
- 1.64%
- Beta (5Y)
- 0.25
- 52-week high
- ₩98,100.00
- 52-week low
- ₩63,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.